The daily glycemic profile was assessed by CGM sensor tracing and we found that vildagliptin as an add-on to insulin delivered by AHCL mainly improved postprandial hyperglycemia, although pre-iftar blood glucose levels were similar in both groups. This evidence concerns the gene INS and Hyperglycemia.